Systemic neutralization of TGF-β attenuates osteoarthritis

Annals of the New York Academy of Sciences

Volumn 1376, Issue 1, 2016, Pages 53-64

  Xie, Liang ^a,b   Tintani, Francis ^a   Wang, Xiao ^a   Li, Fengfeng ^a   Zhen, Gehua ^a   Qiu, Tao ^a   Wan, Mei ^a   Crane, Janet ^a   Chen, Qianming ^b   Cao, Xu ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SICHUAN UNIVERSITY   (China)

Author keywords

antibody; cartilage; osteoarthritis; subchondral bone; TGF

Indexed keywords

1D11 ANTIBODY; AGGRECAN; CD31 ANTIGEN; COLLAGEN TYPE 10; COLLAGEN TYPE 2; COLLAGENASE 3; NESTIN; NEUTRALIZING ANTIBODY; PROTEOGLYCAN; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSCRIPTION FACTOR OSTERIX; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ARTICULAR CARTILAGE; BONE DEVELOPMENT; BONE MICROARCHITECTURE; BONE REMODELING; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIAL PROGENITOR CELL; HYALINE CARTILAGE; MESENCHYMAL STEM CELL; MOUSE; MOUSE MODEL; NONHUMAN; OSSIFICATION; OSTEOARTHRITIS; OSTEOBLAST; PROTEIN EXPRESSION; ANIMAL; ANTERIOR CRUCIATE LIGAMENT INJURIES; BONE; C57BL MOUSE; CARTILAGE; DRUG EFFECTS; IMMUNOLOGY; INJECTION; PATHOLOGY; SERODIAGNOSIS;

ANIMALS; ANTERIOR CRUCIATE LIGAMENT INJURIES; ANTIBODIES, NEUTRALIZING; BONE AND BONES; CARTILAGE; DISEASE PROGRESSION; INJECTIONS; MICE, INBRED C57BL; NEUTRALIZATION TESTS; OSTEOARTHRITIS; OSTEOGENESIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 84956939694     PISSN: 00778923     EISSN: 17496632     Source Type: Journal    
DOI: 10.1111/nyas.13000     Document Type: Article

References (60)

1. Hootman, J.M. & C.G. Helmick. 2006. Projections of US prevalence of arthritis and associated activity limitations. Arthritis Rheum. 54: 226–229.
2. Lawrence, R.C. et al. 2008. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 58: 26–35.
3. Berenbaum, F. 2011. Osteoarthritis year 2010 in review: pharmacological therapies. Osteoarthritis Cartilage 19: 361–365.
4. Hawker, G.A. et al. 2011. Osteoarthritis year 2010 in review: non-pharmacologic therapy. Osteoarthritis Cartilage 19: 366–374.
5. Madry, H., C.N. van Dijk & M. Mueller-Gerbl. 2010. The basic science of the subchondral bone. Knee Surg. Sports Traumatol. Arthrosc. 18: 419–433.
6. Burr, D.B. & E.L. Radin. 2003. Microfractures and microcracks in subchondral bone: are they relevant to osteoarthrosis? Rheum. Dis. Clin. North Am. 29: 675–685.
7. Cao, X. 2011. Targeting osteoclast–osteoblast communication. Nat. Med. 17: 1344–1346.
8. Tang, Y. et al. 2009. TGF-beta1-induced migration of bone mesenchymal stem cells couples bone resorption with formation. Nat. Med. 15: 757–765.
9. Zhen, G. & X. Cao. 2014. Targeting TGFbeta signaling in subchondral bone and articular cartilage homeostasis. Trends Pharmacol. Sci. 35: 227–236.
10. Blaney Davidson, E.N., P.M. van der Kraan & W.B. van den Berg. 2007. TGF-beta and osteoarthritis. Osteoarthritis Cartilage 15: 597–604.
11. Scharstuhl, A. et al. 2002. Inhibition of endogenous TGF-beta during experimental osteoarthritis prevents osteophyte formation and impairs cartilage repair. J. Immunol. 169: 507–514.
12. Shen, J., S. Li & D. Chen. 2014. TGF-beta signaling and the development of osteoarthritis. Bone Res. 2: pii: 14002.
13. Xu, X. et al. 2015. Aberrant activation of TGF-beta in subchondral bone at the onset of rheumatoid arthritis joint destruction. J. Bone Miner. Res. 30: 2033–2043.
14. Zhen, G. et al. 2013. Inhibition of TGF-beta signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis. Nat. Med. 19: 704–712.
15. Hunter, D.J. et al. 2006. Increase in bone marrow lesions associated with cartilage loss: a longitudinal magnetic resonance imaging study of knee osteoarthritis. Arthritis Rheum. 54: 1529–1535.
16. Scharstuhl, A. et al. 2003. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum. 48: 3442–3451.
17. Stein, V. et al. 2012. Pattern of joint damage in persons with knee osteoarthritis and concomitant ACL tears. Rheumatol. Int. 32: 1197–1208.
18. Pickarski, M. et al. 2011. Molecular changes in articular cartilage and subchondral bone in the rat anterior cruciate ligament transection and meniscectomized models of osteoarthritis. BMC Musculoskelet. Disord. 12: 197.
19. Ashraf, S. & D.A. Walsh. 2008. Angiogenesis in osteoarthritis. Curr. Opin. Rheumatol. 20: 573–580.
20. Suri, S. et al. 2007. Neurovascular invasion at the osteochondral junction and in osteophytes in osteoarthritis. Ann. Rheum. Dis. 66: 1423–1428.
21. Qiu, T. et al. 2010. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Nat. Cell Biol. 12: 224–234.
22. Edwards, J.R. et al. 2010. Inhibition of TGF-beta signaling by 1D11 antibody treatment increases bone mass and quality in vivo. J. Bone Miner. Res. 25: 2419–2426.
23. Pritzker, K.P. et al. 2006. Osteoarthritis cartilage histopathology: grading and staging. Osteoarthritis Cartilage 14: 13–29.
24. Neuhold, L.A. et al. 2001. Postnatal expression in hyaline cartilage of constitutively active human collagenase-3 (MMP-13) induces osteoarthritis in mice. J. Clin. Invest. 107: 35–44.
25. Wang, M. et al. 2013. MMP13 is a critical target gene during the progression of osteoarthritis. Arthritis Res. Ther. 15: R5
26. Tchetina, E.V. 2011. Developmental mechanisms in articular cartilage degradation in osteoarthritis. Arthritis 2011: 683970.
27. Hahn, M. et al. 1992. Trabecular bone pattern factor—a new parameter for simple quantification of bone microarchitecture. Bone 13: 327–330.
28. Mendez-Ferrer, S. et al. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829–834.
29. Wiese, C. et al. 2004. Nestin expression—a property of multi-lineage progenitor cells? Cell. Mol. Life Sci. 61: 2510–2522.
30. Lotz, M. 2012. Osteoarthritis year 2011 in review: biology. Osteoarthritis Cartilage 20: 192–196.
31. Goldring, M.B. & S.R. Goldring. 2010. Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis. Ann. N.Y. Acad. Sci. 1192: 230–237.
32. Imhof, H. et al. 1999. Importance of subchondral bone to articular cartilage in health and disease. Top. Magn. Reson. Imaging 10: 180–192.
33. Sharma, A.R. et al. 2013. Interplay between cartilage and subchondral bone contributing to pathogenesis of osteoarthritis. Int. J. Mol. Sci. 14: 19805–19830.
34. Lories, R.J. & F.P. Luyten. 2011. The bone–cartilage unit in osteoarthritis. Nat. Rev. Rheumatol. 7: 43–49.
35. Lotz, M., J. Kekow & D.A. Carson. 1990. Transforming growth factor-beta and cellular immune responses in synovial fluids. J. Immunol. 144: 4189–4194.
36. Schlaak, J.F. et al. 1996. Different cytokine profiles in the synovial fluid of patients with osteoarthritis, rheumatoid arthritis and seronegative spondylarthropathies. Clin. Exp. Rheumatol. 14: 155–162.
37. Hulth, A. et al. 1996. Effect of transforming growth factor-beta and platelet-derived growth factor-BB on articular cartilage in rats. J. Orthop. Res. 14: 547–553.
38. van Beuningen, H.M. et al. 2000. Osteoarthritis-like changes in the murine knee joint resulting from intra-articular transforming growth factor-beta injections. Osteoarthritis Cartilage 8: 25–33.
39. Bakker, A.C. et al. 2001. Overexpression of active TGF-beta-1 in the murine knee joint: evidence for synovial-layer-dependent chondro-osteophyte formation. Osteoarthritis Cartilage 9: 128–136.
40. Suri, S. & D.A. Walsh. 2012. Osteochondral alterations in osteoarthritis. Bone 51: 204–211.
41. Hunter, D.J. et al. 2009. Bone marrow lesions from osteoarthritis knees are characterized by sclerotic bone that is less well mineralized. Arthritis Res. Ther. 11: R11.
42. Mendez-Ferrer, S. et al. 2010. Mesenchymal and haematopoietic stem cells form a unique bone marrow niche. Nature 466: 829–834.
43. + sphere-forming mesenchymal stem cells capable of hematopoietic progenitor cell expansion. J. Exp. Med. 210: 1351–1367.
44. Ono, N. et al. 2014. Vasculature-associated cells expressing nestin in developing bones encompass early cells in the osteoblast and endothelial lineage. Dev. Cell 29: 330–339.
45. Xie, L. et al. 2015. Characterization of nestin, a selective marker for bone marrow derived mesenchymal stem cells. Stem Cells Int. 2015: 762098.
46. Xie, H. et al. 2014. PDGF-BB secreted by preosteoclasts induces angiogenesis during coupling with osteogenesis. Nat. Med. 20: 1270–1278.
47. Kusumbe, A.P., S.K. Ramasamy & R.H. Adams. 2014. Coupling of angiogenesis and osteogenesis by a specific vessel subtype in bone. Nature 507: 323–328.
48. Arnoldi, C.C., H. Linderholm & H. Mussbichler. 1972. Venous engorgement and intraosseous hypertension in osteoarthritis of the hip. J. Bone Joint Surg. Br. 54: 409–421.
49. Mapp, P.I. et al. 2008. Angiogenesis in two animal models of osteoarthritis. Osteoarthritis Cartilage 16: 61–69.
50. Cunha, S.I. & K. Pietras. 2011. ALK1 as an emerging target for antiangiogenic therapy of cancer. Blood 117: 6999–7006.
51. Guiducci, S. et al. 2011. Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro. Ann. Rheum. Dis. 70: 2011–2021.
52. Wan, M. et al. 2012. Injury-activated transforming growth factor beta controls mobilization of mesenchymal stem cells for tissue remodeling. Stem Cells 30: 2498–2511.
53. Pooler, A.R. et al. 2001. “Cartilage in health and disease.” In Arthritis and Allied Conditions: A Textbook of Rheumatology. W. Koopman, Ed.: 226–284. Philadelphia, PA: Lippincott Williams & Wilkins.
54. Poole, A.R. et al. 2002. Type II collagen degradation and its regulation in articular cartilage in osteoarthritis. Ann. Rheum. Dis. 61(Suppl. 2): ii78–ii81.
55. Sophia Fox, A.J., A. Bedi & S.A. Rodeo. 2009. The basic science of articular cartilage: structure, composition, and function. Sports Health 1: 461–468.
56. Kiani, C. et al. 2002. Structure and function of aggrecan. Cell Res. 12: 19–32.
57. Blaney Davidson, E.N. et al. 2006. Expression of transforming growth factor-beta (TGFbeta) and the TGFbeta signalling molecule SMAD-2P in spontaneous and instability-induced osteoarthritis: role in cartilage degradation, chondrogenesis and osteophyte formation. Ann. Rheum. Dis. 65: 1414–1421.
58. van Beuningen, H.M. et al. 1994. Transforming growth factor-beta 1 stimulates articular chondrocyte proteoglycan synthesis and induces osteophyte formation in the murine knee joint. Lab. Invest. 71: 279–290.
59. Shen, J. et al. 2013. Deletion of the transforming growth factor beta receptor type II gene in articular chondrocytes leads to a progressive osteoarthritis-like phenotype in mice. Arthritis Rheum. 65: 3107–3119.
60. Kamekura, S. et al. 2005. Osteoarthritis development in novel experimental mouse models induced by knee joint instability. Osteoarthritis Cartilage 13: 632–641.